Breast Neoplasms News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breast neoplasms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breast Neoplasms Today - Breaking & Trending Today

Ultrasound-guided localization with magnetic seeds effective for localizing small non-palpable breast lesions

Italy: A recent study published in Clinical Breast Cancer has suggested that image-guided localization with magnetic seeds is a safe, easy, effective, and reliable method for localizing nonpalpable. ....

Istituto Nazionale Tumori , Catherine Depretto , National Cancer Institute , Nazionale Tumori , Via Giacomo , Clinical Breast , Clinical Breast Cancer , Breast Neoplasms , Magnetic Seed , Breast Cancer , On Palpable , Breast Lesions ,

"Update on the Recommendations on Breast Cancer Screening by the Cancer" by T. H.F. Tsang, K. H. Wong et al.

Breast cancer (BC) is the most common cancer among women in Hong Kong. The Food and Health Bureau commissioned The University of Hong Kong (HKU) to conduct the Hong Kong Breast Cancer Study (HKBCS) with the aim of identifying relevant risk factors for BC in Hong Kong and developing a locally validated BC risk assessment tool for Hong Kong Chinese women. After consideration of the most recent international and local scientific evidence including findings of the HKBCS, the Cancer Expert Working Group on Cancer Prevention and Screening (CEWG) has reviewed and updated its BC screening recommendations. Existing recommendations were preserved for women at high risk and slightly changed for women at moderate risk. The following major updates have been made concerning recommendations for other women in the general population: Women aged 44 to 69 with certain combinations of personalised risk factors (including presence of history of BC among first-degree relative, a prior diagnosis of benign b ....

Hong Kong , University Of Hong Kong , Hong Kong General , Cancer Expert Working Group On Prevention , Health Bureau , Hong Kong Breast Cancer Study , Hong Kong Chinese , Cancer Expert Working Group , Cancer Prevention , Breast Neoplasms , Hong Kong , Mass Screening , Risk Assessment ,

MiRNA-disease association prediction via hypergraph learning based on high-dimensionality features.


Apr 26, 2021
MicroRNAs (miRNAs) have been confirmed to have close relationship with various human complex diseases. The identification of disease-related miRNAs provides great insights into the underlying pathogenesis of diseases. However, it is still a big challenge to identify which miRNAs are related to diseases. As experimental methods are in general expensive and time-consuming, it is important to develop efficient computational models to discover potential miRNA-disease associations.
This study presents a novel prediction method called HFHLMDA, which is based on high-dimensionality features and hypergraph learning, to reveal the association between diseases and miRNAs. Firstly, the miRNA functional similarity and the disease semantic similarity are integrated to form an informative high-dimensionality feature vector. Then, a hypergraph is constructed by the K-Nearest-Neighbor (KNN) method, in which each miRNA-disease pair and its k most relevant neighbors are linked ....

Hepatocellular Carcinoma , Breast Neoplasms ,

Revive Therapeutics Ltd. signs asset purchase agreement with Newscope Capital Corporation to acquire the full rights to PharmaTher Inc.'s intellectual property relating to psilocybin


Revive Therapeutics signs asset purchase agreement with Newscope Capital to acquire the full rights to PharmaTher s IP relating to psilocybin
PharmaTher, a wholly-owned subsidiary of Newscope, is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals
In addition to the up to C$10M purchase price, Revive will also pay Newscope a low single-digit royalty on all future net sales of products derived from the acquired assets
Revive Therapeutics Ltd. (CSE:RVV) (OTCMKTS:RVVTF) said that, further to its press release dated December 21, 2020, it has entered into an asset purchase agreement with Newscope Capital Corporation to acquire the full rights to PharmaTher Inc.’s intellectual property relating to psilocybin. ....

United States , Michael Frank , Gavin Williams , Fabio Chianelli , Pharmather Inc , Drug Administration , Trademark Office , University Of Wisconsin , National Health Research Institutes , Newscope Capital Corporation , Psilocin Pharma Corp , Carolina State University , Neurological Brain Injury , States Provisional Application Serial , United States Provisional Application Serial , Liver Carcinoma , Breast Neoplasms , Kidney Neoplasms , Acute Myeloid , Pharmaceutical Combination Therapies , North Carolina State University , Orphan Drug , Fast Track , Breakthrough Therapy , Rare Pediatric Disease , ஒன்றுபட்டது மாநிலங்களில் ,